August 07, 2025
A Maryland federal judge on Thursday granted final approval to a $15 million settlement to close out a stockholder derivative suit claiming Emergent BioSolutions Inc. and its top brass made a mint selling stock before their allegedly lax oversight led to the contamination of over 15 million Johnson & Johnson COVID-19 vaccine doses.
June 30, 2021
An Illinois pension fund slapped top directors at Emergent BioSolutions Inc. with a derivative suit claiming board members made a mint selling stock before their lax oversight led to the contamination of over 15 million Johnson & Johnson COVID-19 vaccine doses.